{"entity":{"type":"insider","cik":"0001603333","url":"/insider/0001603333","json_url":"/insider/0001603333.json","name":"Deerfield Private Design Fund III, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":208,"n_filings":50,"first":"2014-08-05","last":"2026-03-02","span_basis":"filed_date"},"name_variants":[{"name":"Deerfield Private Design Fund III, L.P.","source":"filing","n_filings":50,"first_seen":"2014-08-05","last_seen":"2026-03-02"}],"transactions":[{"id":6136162,"accession":"0001193805-26-000205","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193805-26-000205","line_url":"/filing/0001193805-26-000205#line-4","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Larimar Therapeutics, Inc.","issuer_ticker":"LRMR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Mgmt HIF, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P.; Deerfield Mgmt L.P.; Deerfield Private Design Fund IV, L.P.; Deerfield Healthcare Innovations Fund, L.P.; Deerfield Mgmt IV, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Private Design Fund III, L.P.; Deerfield Mgmt III, L.P.; Flynn James E","owner_url":null,"role":"Director, Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000000.0,"shares_display":"2,000,000","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":10000000.0,"total_display":"10,000,000.00","shares_owned_after":6207982.0,"shares_owned_after_display":"6,207,982","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-02-27","filed_date":"2026-03-02","scope":"insider"},{"id":6136158,"accession":"0001193805-26-000205","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193805-26-000205","line_url":"/filing/0001193805-26-000205#line-3","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Larimar Therapeutics, Inc.","issuer_ticker":"LRMR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Mgmt HIF, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P.; Deerfield Mgmt L.P.; Deerfield Private Design Fund IV, L.P.; Deerfield Healthcare Innovations Fund, L.P.; Deerfield Mgmt IV, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Private Design Fund III, L.P.; Deerfield Mgmt III, L.P.; Flynn James E","owner_url":null,"role":"Director, Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1084012.0,"shares_display":"1,084,012","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":5420060.0,"total_display":"5,420,060.00","shares_owned_after":10622957.0,"shares_owned_after_display":"10,622,957","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-02-27","filed_date":"2026-03-02","scope":"insider"},{"id":6136154,"accession":"0001193805-26-000205","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193805-26-000205","line_url":"/filing/0001193805-26-000205#line-2","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Larimar Therapeutics, Inc.","issuer_ticker":"LRMR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Mgmt HIF, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P.; Deerfield Mgmt L.P.; Deerfield Private Design Fund IV, L.P.; Deerfield Healthcare Innovations Fund, L.P.; Deerfield Mgmt IV, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Private Design Fund III, L.P.; Deerfield Mgmt III, L.P.; Flynn James E","owner_url":null,"role":"Director, Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1084010.0,"shares_display":"1,084,010","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":5420050.0,"total_display":"5,420,050.00","shares_owned_after":10622928.0,"shares_owned_after_display":"10,622,928","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-02-27","filed_date":"2026-03-02","scope":"insider"},{"id":6136150,"accession":"0001193805-26-000205","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-26-000205","line_url":"/filing/0001193805-26-000205#line-1","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Larimar Therapeutics, Inc.","issuer_ticker":"LRMR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Mgmt HIF, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P.; Deerfield Mgmt L.P.; Deerfield Private Design Fund IV, L.P.; Deerfield Healthcare Innovations Fund, L.P.; Deerfield Mgmt IV, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Private Design Fund III, L.P.; Deerfield Mgmt III, L.P.; Flynn James E","owner_url":null,"role":"Director, Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":831978.0,"shares_display":"831,978","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":4159890.0,"total_display":"4,159,890.00","shares_owned_after":8153107.0,"shares_owned_after_display":"8,153,107","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-02-27","filed_date":"2026-03-02","scope":"insider"},{"id":5143787,"accession":"0001193805-25-001155","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193805-25-001155","line_url":"/filing/0001193805-25-001155#line-3","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Larimar Therapeutics, Inc.","issuer_ticker":"LRMR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Flynn James E; Deerfield Healthcare Innovations Fund, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Mgmt L.P.; Deerfield Mgmt IV, L.P.; Deerfield Private Design Fund IV, L.P.; Deerfield Mgmt III, L.P.; Deerfield Private Design Fund III, L.P.; Deerfield Mgmt HIF, L.P.","owner_url":null,"role":"Director, Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3387539.0,"shares_display":"3,387,539","price_per_share":3.2,"price_display":"3.20","price_state":"stated","total_value":10840124.8,"total_display":"10,840,124.80","shares_owned_after":9538945.0,"shares_owned_after_display":"9,538,945","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-07-31","filed_date":"2025-08-04","scope":"insider"},{"id":5143783,"accession":"0001193805-25-001155","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193805-25-001155","line_url":"/filing/0001193805-25-001155#line-2","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Larimar Therapeutics, Inc.","issuer_ticker":"LRMR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Flynn James E; Deerfield Healthcare Innovations Fund, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Mgmt L.P.; Deerfield Mgmt IV, L.P.; Deerfield Private Design Fund IV, L.P.; Deerfield Mgmt III, L.P.; Deerfield Private Design Fund III, L.P.; Deerfield Mgmt HIF, L.P.","owner_url":null,"role":"Director, Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3387529.0,"shares_display":"3,387,529","price_per_share":3.2,"price_display":"3.20","price_state":"stated","total_value":10840092.8,"total_display":"10,840,092.80","shares_owned_after":9538918.0,"shares_owned_after_display":"9,538,918","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-07-31","filed_date":"2025-08-04","scope":"insider"},{"id":5143779,"accession":"0001193805-25-001155","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-25-001155","line_url":"/filing/0001193805-25-001155#line-1","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Larimar Therapeutics, Inc.","issuer_ticker":"LRMR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Flynn James E; Deerfield Healthcare Innovations Fund, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Mgmt L.P.; Deerfield Mgmt IV, L.P.; Deerfield Private Design Fund IV, L.P.; Deerfield Mgmt III, L.P.; Deerfield Private Design Fund III, L.P.; Deerfield Mgmt HIF, L.P.","owner_url":null,"role":"Director, Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2599932.0,"shares_display":"2,599,932","price_per_share":3.2,"price_display":"3.20","price_state":"stated","total_value":8319782.4,"total_display":"8,319,782.40","shares_owned_after":7321129.0,"shares_owned_after_display":"7,321,129","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-07-31","filed_date":"2025-08-04","scope":"insider"},{"id":4426836,"accession":"0001193805-25-000959","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193805-25-000959","line_url":"/filing/0001193805-25-000959#line-2","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Private Design Fund IV, L.P.; Deerfield Mgmt IV, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Flynn James E; Deerfield Private Design Fund III, L.P.; Deerfield Mgmt III, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":370075.0,"shares_display":"370,075","price_per_share":18.46,"price_display":"18.46","price_state":"stated","total_value":6831584.5,"total_display":"6,831,584.50","shares_owned_after":4887254.0,"shares_owned_after_display":"4,887,254","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-06-27","filed_date":"2025-07-01","scope":"insider"},{"id":4426833,"accession":"0001193805-25-000959","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-25-000959","line_url":"/filing/0001193805-25-000959#line-1","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Private Design Fund IV, L.P.; Deerfield Mgmt IV, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Flynn James E; Deerfield Private Design Fund III, L.P.; Deerfield Mgmt III, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":370074.0,"shares_display":"370,074","price_per_share":18.46,"price_display":"18.46","price_state":"stated","total_value":6831566.04,"total_display":"6,831,566.04","shares_owned_after":4887254.0,"shares_owned_after_display":"4,887,254","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-06-27","filed_date":"2025-07-01","scope":"insider"},{"id":3218003,"accession":"0001193805-24-001348","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001193805-24-001348","line_url":"/filing/0001193805-24-001348#line-8","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Private Design Fund IV, L.P.; Flynn James E; Deerfield Private Design Fund III, L.P.; Deerfield Mgmt III, L.P.; Deerfield Mgmt IV, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9554.0,"shares_display":"9,554","price_per_share":17.77,"price_display":"17.77","price_state":"stated","total_value":169774.58,"total_display":"169,774.58","shares_owned_after":5257329.0,"shares_owned_after_display":"5,257,329","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-11-12","filed_date":"2024-11-13","scope":"insider"},{"id":3217998,"accession":"0001193805-24-001348","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001193805-24-001348","line_url":"/filing/0001193805-24-001348#line-7","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Private Design Fund IV, L.P.; Flynn James E; Deerfield Private Design Fund III, L.P.; Deerfield Mgmt III, L.P.; Deerfield Mgmt IV, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9553.0,"shares_display":"9,553","price_per_share":17.77,"price_display":"17.77","price_state":"stated","total_value":169756.81,"total_display":"169,756.81","shares_owned_after":5257328.0,"shares_owned_after_display":"5,257,328","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-11-12","filed_date":"2024-11-13","scope":"insider"},{"id":3217993,"accession":"0001193805-24-001348","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001193805-24-001348","line_url":"/filing/0001193805-24-001348#line-6","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Private Design Fund IV, L.P.; Flynn James E; Deerfield Private Design Fund III, L.P.; Deerfield Mgmt III, L.P.; Deerfield Mgmt IV, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7854.0,"shares_display":"7,854","price_per_share":17.16,"price_display":"17.16","price_state":"stated","total_value":134774.64,"total_display":"134,774.64","shares_owned_after":5266881.0,"shares_owned_after_display":"5,266,881","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-11-12","filed_date":"2024-11-13","scope":"insider"},{"id":3217985,"accession":"0001193805-24-001348","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001193805-24-001348","line_url":"/filing/0001193805-24-001348#line-5","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Private Design Fund IV, L.P.; Flynn James E; Deerfield Private Design Fund III, L.P.; Deerfield Mgmt III, L.P.; Deerfield Mgmt IV, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7853.0,"shares_display":"7,853","price_per_share":17.16,"price_display":"17.16","price_state":"stated","total_value":134757.48,"total_display":"134,757.48","shares_owned_after":5266883.0,"shares_owned_after_display":"5,266,883","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-11-12","filed_date":"2024-11-13","scope":"insider"},{"id":3217981,"accession":"0001193805-24-001348","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193805-24-001348","line_url":"/filing/0001193805-24-001348#line-4","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Private Design Fund IV, L.P.; Flynn James E; Deerfield Private Design Fund III, L.P.; Deerfield Mgmt III, L.P.; Deerfield Mgmt IV, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":223632.0,"shares_display":"223,632","price_per_share":18.15,"price_display":"18.15","price_state":"stated","total_value":4058920.8,"total_display":"4,058,920.80","shares_owned_after":5274736.0,"shares_owned_after_display":"5,274,736","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-11-11","filed_date":"2024-11-13","scope":"insider"},{"id":3217975,"accession":"0001193805-24-001348","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193805-24-001348","line_url":"/filing/0001193805-24-001348#line-3","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Private Design Fund IV, L.P.; Flynn James E; Deerfield Private Design Fund III, L.P.; Deerfield Mgmt III, L.P.; Deerfield Mgmt IV, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":223632.0,"shares_display":"223,632","price_per_share":18.15,"price_display":"18.15","price_state":"stated","total_value":4058920.8,"total_display":"4,058,920.80","shares_owned_after":5274735.0,"shares_owned_after_display":"5,274,735","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-11-11","filed_date":"2024-11-13","scope":"insider"},{"id":3217963,"accession":"0001193805-24-001348","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193805-24-001348","line_url":"/filing/0001193805-24-001348#line-2","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Private Design Fund IV, L.P.; Flynn James E; Deerfield Private Design Fund III, L.P.; Deerfield Mgmt III, L.P.; Deerfield Mgmt IV, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40596.0,"shares_display":"40,596","price_per_share":17.45,"price_display":"17.45","price_state":"stated","total_value":708400.2,"total_display":"708,400.20","shares_owned_after":5498368.0,"shares_owned_after_display":"5,498,368","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-11-11","filed_date":"2024-11-13","scope":"insider"},{"id":3217957,"accession":"0001193805-24-001348","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-24-001348","line_url":"/filing/0001193805-24-001348#line-1","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"ARS Pharmaceuticals, Inc.","issuer_ticker":"SPRY","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Private Design Fund IV, L.P.; Flynn James E; Deerfield Private Design Fund III, L.P.; Deerfield Mgmt III, L.P.; Deerfield Mgmt IV, L.P.","owner_url":null,"role":"Ten percent owner","officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40596.0,"shares_display":"40,596","price_per_share":17.45,"price_display":"17.45","price_state":"stated","total_value":708400.2,"total_display":"708,400.20","shares_owned_after":5498367.0,"shares_owned_after_display":"5,498,367","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-11-11","filed_date":"2024-11-13","scope":"insider"},{"id":2505760,"accession":"0001193805-24-000245","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193805-24-000245","line_url":"/filing/0001193805-24-000245#line-3","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Larimar Therapeutics, Inc.","issuer_ticker":"LRMR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Private Design Fund IV, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Mgmt HIF, L.P.; Deerfield Mgmt III, L.P.; Deerfield Private Design Fund III, L.P.; Flynn James E; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Mgmt L.P.; Deerfield Mgmt IV, L.P.; Deerfield Healthcare Innovations Fund, L.P.","owner_url":null,"role":"Director, Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1430206.0,"shares_display":"1,430,206","price_per_share":8.74,"price_display":"8.74","price_state":"stated","total_value":12500000.44,"total_display":"12,500,000.44","shares_owned_after":6151406.0,"shares_owned_after_display":"6,151,406","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-02-16","filed_date":"2024-02-16","scope":"insider"},{"id":2505755,"accession":"0001193805-24-000245","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193805-24-000245","line_url":"/filing/0001193805-24-000245#line-2","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Larimar Therapeutics, Inc.","issuer_ticker":"LRMR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Private Design Fund IV, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Mgmt HIF, L.P.; Deerfield Mgmt III, L.P.; Deerfield Private Design Fund III, L.P.; Flynn James E; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Mgmt L.P.; Deerfield Mgmt IV, L.P.; Deerfield Healthcare Innovations Fund, L.P.","owner_url":null,"role":"Director, Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1430206.0,"shares_display":"1,430,206","price_per_share":8.74,"price_display":"8.74","price_state":"stated","total_value":12500000.44,"total_display":"12,500,000.44","shares_owned_after":6151389.0,"shares_owned_after_display":"6,151,389","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-02-16","filed_date":"2024-02-16","scope":"insider"},{"id":2505748,"accession":"0001193805-24-000245","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-24-000245","line_url":"/filing/0001193805-24-000245#line-1","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Larimar Therapeutics, Inc.","issuer_ticker":"LRMR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Private Design Fund IV, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Mgmt HIF, L.P.; Deerfield Mgmt III, L.P.; Deerfield Private Design Fund III, L.P.; Flynn James E; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Mgmt L.P.; Deerfield Mgmt IV, L.P.; Deerfield Healthcare Innovations Fund, L.P.","owner_url":null,"role":"Director, Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1430205.0,"shares_display":"1,430,205","price_per_share":8.74,"price_display":"8.74","price_state":"stated","total_value":12499991.7,"total_display":"12,499,991.70","shares_owned_after":4207982.0,"shares_owned_after_display":"4,207,982","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-02-16","filed_date":"2024-02-16","scope":"insider"},{"id":6667585,"accession":"0001193805-22-001817","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001193805-22-001817","line_url":"/filing/0001193805-22-001817#line-9","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Oncorus, Inc.","issuer_ticker":"ONCR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Healthcare Innovations Fund, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Mgmt HIF, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Mgmt L.P.; Flynn James E; Deerfield Mgmt III, L.P.; Deerfield Private Design Fund III, L.P.","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":61826.0,"shares_display":"61,826","price_per_share":0.27,"price_display":"0.27","price_state":"stated","total_value":16693.02,"total_display":"16,693.02","shares_owned_after":1156309.0,"shares_owned_after_display":"1,156,309","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-30","filed_date":"2022-12-30","scope":"insider"},{"id":6667584,"accession":"0001193805-22-001817","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001193805-22-001817","line_url":"/filing/0001193805-22-001817#line-8","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Oncorus, Inc.","issuer_ticker":"ONCR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Healthcare Innovations Fund, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Mgmt HIF, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Mgmt L.P.; Flynn James E; Deerfield Mgmt III, L.P.; Deerfield Private Design Fund III, L.P.","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":61826.0,"shares_display":"61,826","price_per_share":0.27,"price_display":"0.27","price_state":"stated","total_value":16693.02,"total_display":"16,693.02","shares_owned_after":1156308.0,"shares_owned_after_display":"1,156,308","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-30","filed_date":"2022-12-30","scope":"insider"},{"id":6667582,"accession":"0001193805-22-001817","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001193805-22-001817","line_url":"/filing/0001193805-22-001817#line-7","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Oncorus, Inc.","issuer_ticker":"ONCR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Healthcare Innovations Fund, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Mgmt HIF, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Mgmt L.P.; Flynn James E; Deerfield Mgmt III, L.P.; Deerfield Private Design Fund III, L.P.","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15220.0,"shares_display":"15,220","price_per_share":0.27,"price_display":"0.27","price_state":"stated","total_value":4109.4,"total_display":"4,109.40","shares_owned_after":284697.0,"shares_owned_after_display":"284,697","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-30","filed_date":"2022-12-30","scope":"insider"},{"id":6667581,"accession":"0001193805-22-001817","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001193805-22-001817","line_url":"/filing/0001193805-22-001817#line-6","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Oncorus, Inc.","issuer_ticker":"ONCR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Healthcare Innovations Fund, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Mgmt HIF, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Mgmt L.P.; Flynn James E; Deerfield Mgmt III, L.P.; Deerfield Private Design Fund III, L.P.","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":63108.0,"shares_display":"63,108","price_per_share":0.26,"price_display":"0.26","price_state":"stated","total_value":16408.08,"total_display":"16,408.08","shares_owned_after":1218134.0,"shares_owned_after_display":"1,218,134","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-29","filed_date":"2022-12-30","scope":"insider"},{"id":6667579,"accession":"0001193805-22-001817","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001193805-22-001817","line_url":"/filing/0001193805-22-001817#line-5","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Oncorus, Inc.","issuer_ticker":"ONCR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Healthcare Innovations Fund, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Mgmt HIF, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Mgmt L.P.; Flynn James E; Deerfield Mgmt III, L.P.; Deerfield Private Design Fund III, L.P.","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":63107.0,"shares_display":"63,107","price_per_share":0.26,"price_display":"0.26","price_state":"stated","total_value":16407.82,"total_display":"16,407.82","shares_owned_after":1218135.0,"shares_owned_after_display":"1,218,135","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-29","filed_date":"2022-12-30","scope":"insider"},{"id":6667578,"accession":"0001193805-22-001817","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193805-22-001817","line_url":"/filing/0001193805-22-001817#line-4","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Oncorus, Inc.","issuer_ticker":"ONCR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Healthcare Innovations Fund, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Mgmt HIF, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Mgmt L.P.; Flynn James E; Deerfield Mgmt III, L.P.; Deerfield Private Design Fund III, L.P.","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15538.0,"shares_display":"15,538","price_per_share":0.26,"price_display":"0.26","price_state":"stated","total_value":4039.88,"total_display":"4,039.88","shares_owned_after":299917.0,"shares_owned_after_display":"299,917","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-29","filed_date":"2022-12-30","scope":"insider"},{"id":6667576,"accession":"0001193805-22-001817","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193805-22-001817","line_url":"/filing/0001193805-22-001817#line-3","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Oncorus, Inc.","issuer_ticker":"ONCR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Healthcare Innovations Fund, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Mgmt HIF, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Mgmt L.P.; Flynn James E; Deerfield Mgmt III, L.P.; Deerfield Private Design Fund III, L.P.","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24757.0,"shares_display":"24,757","price_per_share":0.25,"price_display":"0.25","price_state":"stated","total_value":6189.25,"total_display":"6,189.25","shares_owned_after":1281242.0,"shares_owned_after_display":"1,281,242","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-28","filed_date":"2022-12-30","scope":"insider"},{"id":6667575,"accession":"0001193805-22-001817","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193805-22-001817","line_url":"/filing/0001193805-22-001817#line-2","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Oncorus, Inc.","issuer_ticker":"ONCR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Healthcare Innovations Fund, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Mgmt HIF, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Mgmt L.P.; Flynn James E; Deerfield Mgmt III, L.P.; Deerfield Private Design Fund III, L.P.","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24757.0,"shares_display":"24,757","price_per_share":0.25,"price_display":"0.25","price_state":"stated","total_value":6189.25,"total_display":"6,189.25","shares_owned_after":1281242.0,"shares_owned_after_display":"1,281,242","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-28","filed_date":"2022-12-30","scope":"insider"},{"id":6667573,"accession":"0001193805-22-001817","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-22-001817","line_url":"/filing/0001193805-22-001817#line-1","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Oncorus, Inc.","issuer_ticker":"ONCR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Healthcare Innovations Fund, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Mgmt HIF, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Mgmt L.P.; Flynn James E; Deerfield Mgmt III, L.P.; Deerfield Private Design Fund III, L.P.","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6096.0,"shares_display":"6,096","price_per_share":0.25,"price_display":"0.25","price_state":"stated","total_value":1524.0,"total_display":"1,524.00","shares_owned_after":315455.0,"shares_owned_after_display":"315,455","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-28","filed_date":"2022-12-30","scope":"insider"},{"id":6563897,"accession":"0001193805-22-001793","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001193805-22-001793","line_url":"/filing/0001193805-22-001793#line-6","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Oncorus, Inc.","issuer_ticker":"ONCR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Private Design Fund III, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Mgmt L.P.; Deerfield Mgmt HIF, L.P.; Deerfield Mgmt III, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Healthcare Innovations Fund, L.P.; Flynn James E","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28977.0,"shares_display":"28,977","price_per_share":0.27,"price_display":"0.27","price_state":"stated","total_value":7823.79,"total_display":"7,823.79","shares_owned_after":1305999.0,"shares_owned_after_display":"1,305,999","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-27","filed_date":"2022-12-27","scope":"insider"},{"id":6563894,"accession":"0001193805-22-001793","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001193805-22-001793","line_url":"/filing/0001193805-22-001793#line-5","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Oncorus, Inc.","issuer_ticker":"ONCR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Private Design Fund III, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Mgmt L.P.; Deerfield Mgmt HIF, L.P.; Deerfield Mgmt III, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Healthcare Innovations Fund, L.P.; Flynn James E","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28977.0,"shares_display":"28,977","price_per_share":0.27,"price_display":"0.27","price_state":"stated","total_value":7823.79,"total_display":"7,823.79","shares_owned_after":1305999.0,"shares_owned_after_display":"1,305,999","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-27","filed_date":"2022-12-27","scope":"insider"},{"id":6563891,"accession":"0001193805-22-001793","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193805-22-001793","line_url":"/filing/0001193805-22-001793#line-4","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Oncorus, Inc.","issuer_ticker":"ONCR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Private Design Fund III, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Mgmt L.P.; Deerfield Mgmt HIF, L.P.; Deerfield Mgmt III, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Healthcare Innovations Fund, L.P.; Flynn James E","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7136.0,"shares_display":"7,136","price_per_share":0.27,"price_display":"0.27","price_state":"stated","total_value":1926.72,"total_display":"1,926.72","shares_owned_after":321551.0,"shares_owned_after_display":"321,551","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-27","filed_date":"2022-12-27","scope":"insider"},{"id":6563887,"accession":"0001193805-22-001793","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193805-22-001793","line_url":"/filing/0001193805-22-001793#line-3","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Oncorus, Inc.","issuer_ticker":"ONCR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Private Design Fund III, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Mgmt L.P.; Deerfield Mgmt HIF, L.P.; Deerfield Mgmt III, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Healthcare Innovations Fund, L.P.; Flynn James E","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3693.0,"shares_display":"3,693","price_per_share":0.28,"price_display":"0.28","price_state":"stated","total_value":1034.04,"total_display":"1,034.04","shares_owned_after":1334976.0,"shares_owned_after_display":"1,334,976","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-22","filed_date":"2022-12-27","scope":"insider"},{"id":6563884,"accession":"0001193805-22-001793","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193805-22-001793","line_url":"/filing/0001193805-22-001793#line-2","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Oncorus, Inc.","issuer_ticker":"ONCR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Private Design Fund III, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Mgmt L.P.; Deerfield Mgmt HIF, L.P.; Deerfield Mgmt III, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Healthcare Innovations Fund, L.P.; Flynn James E","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3692.0,"shares_display":"3,692","price_per_share":0.28,"price_display":"0.28","price_state":"stated","total_value":1033.76,"total_display":"1,033.76","shares_owned_after":1334976.0,"shares_owned_after_display":"1,334,976","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-22","filed_date":"2022-12-27","scope":"insider"},{"id":6563880,"accession":"0001193805-22-001793","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-22-001793","line_url":"/filing/0001193805-22-001793#line-1","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Oncorus, Inc.","issuer_ticker":"ONCR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Deerfield Private Design Fund III, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Mgmt L.P.; Deerfield Mgmt HIF, L.P.; Deerfield Mgmt III, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Healthcare Innovations Fund, L.P.; Flynn James E","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":909.0,"shares_display":"909","price_per_share":0.28,"price_display":"0.28","price_state":"stated","total_value":254.52,"total_display":"254.52","shares_owned_after":328687.0,"shares_owned_after_display":"328,687","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-22","filed_date":"2022-12-27","scope":"insider"},{"id":6142077,"accession":"0001193805-22-001764","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001193805-22-001764","line_url":"/filing/0001193805-22-001764#line-9","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Oncorus, Inc.","issuer_ticker":"ONCR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"DEERFIELD PARTNERS, L.P.; Deerfield Mgmt HIF, L.P.; Deerfield Mgmt III, L.P.; Deerfield Private Design Fund III, L.P.; Flynn James E; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Healthcare Innovations Fund, L.P.; Deerfield Mgmt L.P.","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6144.0,"shares_display":"6,144","price_per_share":0.3,"price_display":"0.30","price_state":"stated","total_value":1843.2,"total_display":"1,843.20","shares_owned_after":1338668.0,"shares_owned_after_display":"1,338,668","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-21","filed_date":"2022-12-21","scope":"insider"},{"id":6142074,"accession":"0001193805-22-001764","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001193805-22-001764","line_url":"/filing/0001193805-22-001764#line-8","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Oncorus, Inc.","issuer_ticker":"ONCR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"DEERFIELD PARTNERS, L.P.; Deerfield Mgmt HIF, L.P.; Deerfield Mgmt III, L.P.; Deerfield Private Design Fund III, L.P.; Flynn James E; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Healthcare Innovations Fund, L.P.; Deerfield Mgmt L.P.","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6143.0,"shares_display":"6,143","price_per_share":0.3,"price_display":"0.30","price_state":"stated","total_value":1842.9,"total_display":"1,842.90","shares_owned_after":1338669.0,"shares_owned_after_display":"1,338,669","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-21","filed_date":"2022-12-21","scope":"insider"},{"id":6142069,"accession":"0001193805-22-001764","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001193805-22-001764","line_url":"/filing/0001193805-22-001764#line-7","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Oncorus, Inc.","issuer_ticker":"ONCR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"DEERFIELD PARTNERS, L.P.; Deerfield Mgmt HIF, L.P.; Deerfield Mgmt III, L.P.; Deerfield Private Design Fund III, L.P.; Flynn James E; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Healthcare Innovations Fund, L.P.; Deerfield Mgmt L.P.","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1513.0,"shares_display":"1,513","price_per_share":0.3,"price_display":"0.30","price_state":"stated","total_value":453.9,"total_display":"453.90","shares_owned_after":329596.0,"shares_owned_after_display":"329,596","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-21","filed_date":"2022-12-21","scope":"insider"},{"id":6142065,"accession":"0001193805-22-001764","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001193805-22-001764","line_url":"/filing/0001193805-22-001764#line-6","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Oncorus, Inc.","issuer_ticker":"ONCR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"DEERFIELD PARTNERS, L.P.; Deerfield Mgmt HIF, L.P.; Deerfield Mgmt III, L.P.; Deerfield Private Design Fund III, L.P.; Flynn James E; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Healthcare Innovations Fund, L.P.; Deerfield Mgmt L.P.","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6562.0,"shares_display":"6,562","price_per_share":0.31,"price_display":"0.31","price_state":"stated","total_value":2034.22,"total_display":"2,034.22","shares_owned_after":1344812.0,"shares_owned_after_display":"1,344,812","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-20","filed_date":"2022-12-21","scope":"insider"},{"id":6142062,"accession":"0001193805-22-001764","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001193805-22-001764","line_url":"/filing/0001193805-22-001764#line-5","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Oncorus, Inc.","issuer_ticker":"ONCR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"DEERFIELD PARTNERS, L.P.; Deerfield Mgmt HIF, L.P.; Deerfield Mgmt III, L.P.; Deerfield Private Design Fund III, L.P.; Flynn James E; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Healthcare Innovations Fund, L.P.; Deerfield Mgmt L.P.","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6562.0,"shares_display":"6,562","price_per_share":0.31,"price_display":"0.31","price_state":"stated","total_value":2034.22,"total_display":"2,034.22","shares_owned_after":1344812.0,"shares_owned_after_display":"1,344,812","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-20","filed_date":"2022-12-21","scope":"insider"},{"id":6142058,"accession":"0001193805-22-001764","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193805-22-001764","line_url":"/filing/0001193805-22-001764#line-4","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Oncorus, Inc.","issuer_ticker":"ONCR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"DEERFIELD PARTNERS, L.P.; Deerfield Mgmt HIF, L.P.; Deerfield Mgmt III, L.P.; Deerfield Private Design Fund III, L.P.; Flynn James E; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Healthcare Innovations Fund, L.P.; Deerfield Mgmt L.P.","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1616.0,"shares_display":"1,616","price_per_share":0.31,"price_display":"0.31","price_state":"stated","total_value":500.96,"total_display":"500.96","shares_owned_after":331109.0,"shares_owned_after_display":"331,109","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-20","filed_date":"2022-12-21","scope":"insider"},{"id":6142053,"accession":"0001193805-22-001764","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193805-22-001764","line_url":"/filing/0001193805-22-001764#line-3","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Oncorus, Inc.","issuer_ticker":"ONCR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"DEERFIELD PARTNERS, L.P.; Deerfield Mgmt HIF, L.P.; Deerfield Mgmt III, L.P.; Deerfield Private Design Fund III, L.P.; Flynn James E; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Healthcare Innovations Fund, L.P.; Deerfield Mgmt L.P.","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":44394.0,"shares_display":"44,394","price_per_share":0.29,"price_display":"0.29","price_state":"stated","total_value":12874.26,"total_display":"12,874.26","shares_owned_after":1351374.0,"shares_owned_after_display":"1,351,374","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-19","filed_date":"2022-12-21","scope":"insider"},{"id":6142044,"accession":"0001193805-22-001764","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193805-22-001764","line_url":"/filing/0001193805-22-001764#line-2","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Oncorus, Inc.","issuer_ticker":"ONCR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"DEERFIELD PARTNERS, L.P.; Deerfield Mgmt HIF, L.P.; Deerfield Mgmt III, L.P.; Deerfield Private Design Fund III, L.P.; Flynn James E; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Healthcare Innovations Fund, L.P.; Deerfield Mgmt L.P.","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":44394.0,"shares_display":"44,394","price_per_share":0.29,"price_display":"0.29","price_state":"stated","total_value":12874.26,"total_display":"12,874.26","shares_owned_after":1351374.0,"shares_owned_after_display":"1,351,374","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-19","filed_date":"2022-12-21","scope":"insider"},{"id":6142034,"accession":"0001193805-22-001764","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-22-001764","line_url":"/filing/0001193805-22-001764#line-1","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Oncorus, Inc.","issuer_ticker":"ONCR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"DEERFIELD PARTNERS, L.P.; Deerfield Mgmt HIF, L.P.; Deerfield Mgmt III, L.P.; Deerfield Private Design Fund III, L.P.; Flynn James E; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Healthcare Innovations Fund, L.P.; Deerfield Mgmt L.P.","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10930.0,"shares_display":"10,930","price_per_share":0.29,"price_display":"0.29","price_state":"stated","total_value":3169.7,"total_display":"3,169.70","shares_owned_after":332725.0,"shares_owned_after_display":"332,725","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-19","filed_date":"2022-12-21","scope":"insider"},{"id":6142029,"accession":"0001193805-22-001734","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001193805-22-001734","line_url":"/filing/0001193805-22-001734#line-9","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Oncorus, Inc.","issuer_ticker":"ONCR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Flynn James E; Deerfield Healthcare Innovations Fund, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Private Design Fund III, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Mgmt L.P.; Deerfield Mgmt III, L.P.; Deerfield Mgmt HIF, L.P.","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1375.0,"shares_display":"1,375","price_per_share":0.39,"price_display":"0.39","price_state":"stated","total_value":536.25,"total_display":"536.25","shares_owned_after":1395768.0,"shares_owned_after_display":"1,395,768","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-15","filed_date":"2022-12-15","scope":"insider"},{"id":6142025,"accession":"0001193805-22-001734","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001193805-22-001734","line_url":"/filing/0001193805-22-001734#line-8","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Oncorus, Inc.","issuer_ticker":"ONCR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Flynn James E; Deerfield Healthcare Innovations Fund, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Private Design Fund III, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Mgmt L.P.; Deerfield Mgmt III, L.P.; Deerfield Mgmt HIF, L.P.","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1375.0,"shares_display":"1,375","price_per_share":0.39,"price_display":"0.39","price_state":"stated","total_value":536.25,"total_display":"536.25","shares_owned_after":1395768.0,"shares_owned_after_display":"1,395,768","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-15","filed_date":"2022-12-15","scope":"insider"},{"id":6142020,"accession":"0001193805-22-001734","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001193805-22-001734","line_url":"/filing/0001193805-22-001734#line-7","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Oncorus, Inc.","issuer_ticker":"ONCR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Flynn James E; Deerfield Healthcare Innovations Fund, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Private Design Fund III, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Mgmt L.P.; Deerfield Mgmt III, L.P.; Deerfield Mgmt HIF, L.P.","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":339.0,"shares_display":"339","price_per_share":0.39,"price_display":"0.39","price_state":"stated","total_value":132.21,"total_display":"132.21","shares_owned_after":343655.0,"shares_owned_after_display":"343,655","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-15","filed_date":"2022-12-15","scope":"insider"},{"id":6142016,"accession":"0001193805-22-001734","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001193805-22-001734","line_url":"/filing/0001193805-22-001734#line-6","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Oncorus, Inc.","issuer_ticker":"ONCR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Flynn James E; Deerfield Healthcare Innovations Fund, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Private Design Fund III, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Mgmt L.P.; Deerfield Mgmt III, L.P.; Deerfield Mgmt HIF, L.P.","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3829.0,"shares_display":"3,829","price_per_share":0.38,"price_display":"0.38","price_state":"stated","total_value":1455.02,"total_display":"1,455.02","shares_owned_after":1397143.0,"shares_owned_after_display":"1,397,143","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-14","filed_date":"2022-12-15","scope":"insider"},{"id":6142011,"accession":"0001193805-22-001734","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001193805-22-001734","line_url":"/filing/0001193805-22-001734#line-5","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Oncorus, Inc.","issuer_ticker":"ONCR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Flynn James E; Deerfield Healthcare Innovations Fund, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Private Design Fund III, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Mgmt L.P.; Deerfield Mgmt III, L.P.; Deerfield Mgmt HIF, L.P.","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3828.0,"shares_display":"3,828","price_per_share":0.38,"price_display":"0.38","price_state":"stated","total_value":1454.64,"total_display":"1,454.64","shares_owned_after":1397143.0,"shares_owned_after_display":"1,397,143","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-14","filed_date":"2022-12-15","scope":"insider"},{"id":6142007,"accession":"0001193805-22-001734","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001193805-22-001734","line_url":"/filing/0001193805-22-001734#line-4","is_derivative":false,"issuer_cik":"0001009258","issuer_name":"Oncorus, Inc.","issuer_ticker":"ONCR","issuer_name_source":null,"issuer_url":"/issuer/0001009258","owner_cik":null,"owner_name":"Flynn James E; Deerfield Healthcare Innovations Fund, L.P.; DEERFIELD PARTNERS, L.P.; Deerfield Private Design Fund III, L.P.; DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C); Deerfield Mgmt L.P.; Deerfield Mgmt III, L.P.; Deerfield Mgmt HIF, L.P.","owner_url":null,"role":"Ten percent owner, Other","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":943.0,"shares_display":"943","price_per_share":0.38,"price_display":"0.38","price_state":"stated","total_value":358.34,"total_display":"358.34","shares_owned_after":343994.0,"shares_owned_after_display":"343,994","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-14","filed_date":"2022-12-15","scope":"insider"}],"next_cursor":"2022-12-14|6142007","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001374690","name":"Larimar Therapeutics, Inc.","url":"/issuer/0001374690","role":"Director, Ten percent owner, Other","n_filings":5,"first_seen":"2021-07-02","last_seen":"2026-03-02"},{"type":"issuer","type_label":"ISSUER","cik":"0001671858","name":"ARS Pharmaceuticals, Inc.","url":"/issuer/0001671858","role":"Ten percent owner","n_filings":2,"first_seen":"2024-11-13","last_seen":"2025-07-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001671818","name":"Oncorus, Inc.","url":"/issuer/0001671818","role":"Director, Ten percent owner, Other","n_filings":6,"first_seen":"2020-10-08","last_seen":"2022-12-30"},{"type":"issuer","type_label":"ISSUER","cik":"0001522860","name":"Acutus Medical, Inc.","url":"/issuer/0001522860","role":"Director, Ten percent owner, Other","n_filings":2,"first_seen":"2020-08-12","last_seen":"2021-07-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001126234","name":"LUMOS PHARMA, INC.","url":"/issuer/0001126234","role":"Ten percent owner, Other","n_filings":1,"first_seen":"2021-01-08","last_seen":"2021-01-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001534133","name":"GRAYBUG VISION, INC.","url":"/issuer/0001534133","role":"Ten percent owner, Other","n_filings":1,"first_seen":"2020-10-01","last_seen":"2020-10-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001661998","name":"Homology Medicines, Inc.","url":"/issuer/0001661998","role":"Director, Ten percent owner, Other","n_filings":6,"first_seen":"2018-04-04","last_seen":"2020-01-31"},{"type":"issuer","type_label":"ISSUER","cik":"0001642545","name":"ShockWave Medical, Inc.","url":"/issuer/0001642545","role":"Ten percent owner, Other","n_filings":1,"first_seen":"2019-03-11","last_seen":"2019-03-11"},{"type":"issuer","type_label":"ISSUER","cik":"0001346302","name":"XERIS PHARMACEUTICALS INC","url":"/issuer/0001346302","role":"Ten percent owner, Other","n_filings":5,"first_seen":"2018-06-27","last_seen":"2019-02-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001655759","name":"ARVINAS INC.","url":"/issuer/0001655759","role":"Ten percent owner, Other","n_filings":1,"first_seen":"2018-10-01","last_seen":"2018-10-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001649904","name":"RHYTHM PHARMACEUTICALS, INC.","url":"/issuer/0001649904","role":"Ten percent owner, Other","n_filings":1,"first_seen":"2017-10-10","last_seen":"2017-10-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001628738","name":"Audentes Therapeutics, Inc.","url":"/issuer/0001628738","role":"Ten percent owner, Other","n_filings":1,"first_seen":"2016-07-25","last_seen":"2016-07-25"},{"type":"issuer","type_label":"ISSUER","cik":"0001556263","name":"Syros Pharmaceuticals, Inc.","url":"/issuer/0001556263","role":"Ten percent owner, Other","n_filings":1,"first_seen":"2016-07-06","last_seen":"2016-07-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001652923","name":"AveXis, Inc.","url":"/issuer/0001652923","role":"Ten percent owner, Other","n_filings":1,"first_seen":"2016-02-19","last_seen":"2016-02-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001650664","name":"Editas Medicine, Inc.","url":"/issuer/0001650664","role":"Ten percent owner, Other","n_filings":1,"first_seen":"2016-02-08","last_seen":"2016-02-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001267602","name":"ALIMERA SCIENCES INC","url":"/issuer/0001267602","role":"Ten percent owner, Other","n_filings":8,"first_seen":"2015-10-09","last_seen":"2015-12-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001501989","name":"CytomX Therapeutics, Inc.","url":"/issuer/0001501989","role":"Ten percent owner, Other","n_filings":1,"first_seen":"2015-10-14","last_seen":"2015-10-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001590877","name":"REGENXBIO Inc.","url":"/issuer/0001590877","role":"Ten percent owner, Other","n_filings":1,"first_seen":"2015-09-22","last_seen":"2015-09-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001467652","name":"Neos Therapeutics, Inc.","url":"/issuer/0001467652","role":"Ten percent owner, Other","n_filings":1,"first_seen":"2015-07-28","last_seen":"2015-07-28"},{"type":"issuer","type_label":"ISSUER","cik":"0001339970","name":"aTYR PHARMA INC","url":"/issuer/0001339970","role":"Ten percent owner, Other","n_filings":1,"first_seen":"2015-05-13","last_seen":"2015-05-13"},{"type":"issuer","type_label":"ISSUER","cik":"0001619087","name":"SteadyMed Ltd.","url":"/issuer/0001619087","role":"Ten percent owner, Other","n_filings":1,"first_seen":"2015-03-25","last_seen":"2015-03-25"},{"type":"issuer","type_label":"ISSUER","cik":"0001359931","name":"PROTEON THERAPEUTICS INC","url":"/issuer/0001359931","role":"Ten percent owner, Other","n_filings":1,"first_seen":"2014-10-27","last_seen":"2014-10-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001501756","name":"Avalanche Biotechnologies, Inc.","url":"/issuer/0001501756","role":"Ten percent owner, Other","n_filings":1,"first_seen":"2014-08-05","last_seen":"2014-08-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001603333","retrieved_at":"2026-08-21T17:11:40+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}